PFO
PRAH

Pathstone Family Office’s PRA Health Sciences, Inc. PRAH Stock Holding History

Pathstone Family Office’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-94
Closed -$12K – 1470
2020
Q4 		$12K Buy
+94
New +$10.5K ﹤0.01% 855

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Pathstone Family Office's PRAH Position: Q1 2021 in Review

Pathstone Family Office sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 94 shares — an estimated $12K sold.

Pathstone Family Office first reported a position in PRAH in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Pathstone Family Office reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 94 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $12K.
  • Pathstone Family Office first reported a position in PRA Health Sciences, Inc. in Q4 2020 and held it in 1 quarter.
  • Pathstone Family Office's PRA Health Sciences, Inc. position peaked at $12K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.